nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP1A2—chronic obstructive pulmonary disease	0.505	1	CbGaD
Ramelteon—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0682	0.183	CbGbCtD
Ramelteon—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0682	0.183	CbGbCtD
Ramelteon—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0535	0.143	CbGbCtD
Ramelteon—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0435	0.117	CbGbCtD
Ramelteon—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0294	0.0788	CbGbCtD
Ramelteon—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0287	0.0768	CbGbCtD
Ramelteon—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0281	0.0752	CbGbCtD
Ramelteon—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.025	0.067	CbGbCtD
Ramelteon—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0147	0.0393	CbGbCtD
Ramelteon—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0139	0.0371	CbGbCtD
Ramelteon—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00222	0.0318	CcSEcCtD
Ramelteon—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00198	0.0283	CcSEcCtD
Ramelteon—Thinking abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.0265	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.0254	CcSEcCtD
Ramelteon—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.0217	CcSEcCtD
Ramelteon—Mental disability—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.0211	CcSEcCtD
Ramelteon—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00132	0.0189	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.0013	0.0186	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.0165	CcSEcCtD
Ramelteon—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.0164	CcSEcCtD
Ramelteon—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00113	0.0161	CcSEcCtD
Ramelteon—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.0161	CcSEcCtD
Ramelteon—Influenza—Montelukast—chronic obstructive pulmonary disease	0.0011	0.0158	CcSEcCtD
Ramelteon—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.0156	CcSEcCtD
Ramelteon—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0152	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00105	0.015	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.015	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00103	0.0147	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.0142	CcSEcCtD
Ramelteon—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000907	0.013	CcSEcCtD
Ramelteon—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000865	0.0124	CcSEcCtD
Ramelteon—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000843	0.0121	CcSEcCtD
Ramelteon—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000836	0.012	CcSEcCtD
Ramelteon—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000829	0.0119	CcSEcCtD
Ramelteon—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000829	0.0119	CcSEcCtD
Ramelteon—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000792	0.0113	CcSEcCtD
Ramelteon—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00077	0.011	CcSEcCtD
Ramelteon—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00077	0.011	CcSEcCtD
Ramelteon—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000762	0.0109	CcSEcCtD
Ramelteon—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000751	0.0107	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00073	0.0105	CcSEcCtD
Ramelteon—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000727	0.0104	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000724	0.0104	CcSEcCtD
Ramelteon—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000719	0.0103	CcSEcCtD
Ramelteon—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.00958	CcSEcCtD
Ramelteon—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.00958	CcSEcCtD
Ramelteon—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000669	0.00958	CcSEcCtD
Ramelteon—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000669	0.00958	CcSEcCtD
Ramelteon—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000655	0.00938	CcSEcCtD
Ramelteon—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000655	0.00938	CcSEcCtD
Ramelteon—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000641	0.00918	CcSEcCtD
Ramelteon—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000641	0.00918	CcSEcCtD
Ramelteon—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00904	CcSEcCtD
Ramelteon—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00904	CcSEcCtD
Ramelteon—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000628	0.00899	CcSEcCtD
Ramelteon—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000606	0.00867	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000584	0.00836	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000584	0.00836	CcSEcCtD
Ramelteon—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00058	0.0083	CcSEcCtD
Ramelteon—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00058	0.0083	CcSEcCtD
Ramelteon—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000577	0.00825	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000572	0.00819	CcSEcCtD
Ramelteon—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00057	0.00816	CcSEcCtD
Ramelteon—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.00816	CcSEcCtD
Ramelteon—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000568	0.00813	CcSEcCtD
Ramelteon—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000559	0.00799	CcSEcCtD
Ramelteon—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000557	0.00798	CcSEcCtD
Ramelteon—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00792	CcSEcCtD
Ramelteon—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00792	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000552	0.0079	CcSEcCtD
Ramelteon—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.00784	CcSEcCtD
Ramelteon—MTNR1B—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000548	0.0105	CbGpPWpGaD
Ramelteon—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00775	CcSEcCtD
Ramelteon—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000538	0.00771	CcSEcCtD
Ramelteon—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000536	0.0103	CbGpPWpGaD
Ramelteon—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000534	0.0102	CbGpPWpGaD
Ramelteon—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000528	0.00756	CcSEcCtD
Ramelteon—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000526	0.00752	CcSEcCtD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000525	0.0101	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000525	0.0101	CbGpPWpGaD
Ramelteon—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00747	CcSEcCtD
Ramelteon—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000501	0.00717	CcSEcCtD
Ramelteon—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.0005	0.00959	CbGpPWpGaD
Ramelteon—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000498	0.00713	CcSEcCtD
Ramelteon—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000481	0.00922	CbGpPWpGaD
Ramelteon—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00676	CcSEcCtD
Ramelteon—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00659	CcSEcCtD
Ramelteon—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00659	CcSEcCtD
Ramelteon—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00645	CcSEcCtD
Ramelteon—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000439	0.00628	CcSEcCtD
Ramelteon—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.00628	CcSEcCtD
Ramelteon—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00622	CcSEcCtD
Ramelteon—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00615	CcSEcCtD
Ramelteon—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00607	CcSEcCtD
Ramelteon—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00607	CcSEcCtD
Ramelteon—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000415	0.00595	CcSEcCtD
Ramelteon—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00593	CcSEcCtD
Ramelteon—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000414	0.00794	CbGpPWpGaD
Ramelteon—Headache—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00575	CcSEcCtD
Ramelteon—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00575	CcSEcCtD
Ramelteon—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00573	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.0004	0.00768	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.0004	0.00768	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000399	0.00766	CbGpPWpGaD
Ramelteon—Depression—Prednisone—chronic obstructive pulmonary disease	0.000395	0.00565	CcSEcCtD
Ramelteon—Headache—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00563	CcSEcCtD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000385	0.00738	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000385	0.00738	CbGpPWpGaD
Ramelteon—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00545	CcSEcCtD
Ramelteon—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00545	CcSEcCtD
Ramelteon—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00543	CcSEcCtD
Ramelteon—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00534	CcSEcCtD
Ramelteon—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000371	0.00712	CbGpPWpGaD
Ramelteon—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000363	0.00697	CbGpPWpGaD
Ramelteon—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00515	CcSEcCtD
Ramelteon—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000359	0.00689	CbGpPWpGaD
Ramelteon—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000349	0.0067	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.00497	CcSEcCtD
Ramelteon—MTNR1A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000341	0.00655	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000341	0.00655	CbGpPWpGaD
Ramelteon—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000338	0.00649	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00033	0.00632	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00033	0.00632	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000328	0.00629	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000328	0.00629	CbGpPWpGaD
Ramelteon—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000327	0.00627	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000325	0.00623	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000318	0.0061	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000318	0.0061	CbGpPWpGaD
Ramelteon—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.0045	CcSEcCtD
Ramelteon—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000313	0.00601	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000308	0.00591	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000301	0.00577	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000301	0.00577	CbGpPWpGaD
Ramelteon—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.00577	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000295	0.00565	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000295	0.00565	CbGpPWpGaD
Ramelteon—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.00555	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000288	0.00552	CbGpPWpGaD
Ramelteon—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00543	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000281	0.00538	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000281	0.00538	CbGpPWpGaD
Ramelteon—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000272	0.00522	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00518	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000268	0.00514	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000268	0.00514	CbGpPWpGaD
Ramelteon—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00377	CcSEcCtD
Ramelteon—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00377	CcSEcCtD
Ramelteon—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000261	0.00501	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000258	0.00494	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000258	0.00494	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000255	0.00489	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000255	0.00489	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00361	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000251	0.00482	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000251	0.00482	CbGpPWpGaD
Ramelteon—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000251	0.00481	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00024	0.00461	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000238	0.00456	CbGpPWpGaD
Ramelteon—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000238	0.00456	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00329	CcSEcCtD
Ramelteon—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00329	CcSEcCtD
Ramelteon—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00327	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000226	0.00434	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000226	0.00434	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000224	0.0043	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000224	0.0043	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000224	0.0043	CbGpPWpGaD
Ramelteon—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00419	CbGpPWpGaD
Ramelteon—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00311	CcSEcCtD
Ramelteon—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00311	CcSEcCtD
Ramelteon—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000212	0.00407	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00403	CbGpPWpGaD
Ramelteon—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00403	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.00398	CbGpPWpGaD
Ramelteon—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00295	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000205	0.00394	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000205	0.00394	CbGpPWpGaD
Ramelteon—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000205	0.00393	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.0002	0.00384	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.0002	0.00384	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000199	0.00381	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000199	0.00381	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.00377	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000196	0.00376	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000196	0.00376	CbGpPWpGaD
Ramelteon—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00259	CcSEcCtD
Ramelteon—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00335	CbGpPWpGaD
Ramelteon—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00247	CcSEcCtD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00323	CbGpPWpGaD
Ramelteon—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00239	CcSEcCtD
Ramelteon—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000165	0.00317	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000159	0.00305	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000159	0.00305	CbGpPWpGaD
Ramelteon—Headache—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00226	CcSEcCtD
Ramelteon—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00296	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00289	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00015	0.00289	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00015	0.00289	CbGpPWpGaD
Ramelteon—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00215	CcSEcCtD
Ramelteon—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.00286	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00279	CbGpPWpGaD
Ramelteon—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00279	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00279	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000143	0.00275	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000142	0.00272	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000142	0.00272	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000142	0.00272	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000139	0.00267	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000139	0.00267	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00261	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000129	0.00247	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000129	0.00247	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000128	0.00245	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000127	0.00244	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000127	0.00244	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000127	0.00243	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000127	0.00243	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00239	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00236	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00235	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000121	0.00233	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000121	0.00233	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000121	0.00233	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000121	0.00233	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00225	CbGpPWpGaD
Ramelteon—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00222	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000115	0.00221	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000115	0.00221	CbGpPWpGaD
Ramelteon—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00215	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000111	0.00213	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000111	0.00213	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000108	0.00206	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000106	0.00204	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00194	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000101	0.00193	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000101	0.00193	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	9.93e-05	0.00191	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.53e-05	0.00183	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	9.13e-05	0.00175	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.07e-05	0.00174	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.95e-05	0.00172	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.94e-05	0.00171	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.87e-05	0.0017	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.87e-05	0.0017	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.82e-05	0.00169	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.38e-05	0.00161	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.28e-05	0.00159	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.24e-05	0.00158	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.24e-05	0.00158	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	8.04e-05	0.00154	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.61e-05	0.00146	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.61e-05	0.00146	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.56e-05	0.00145	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.46e-05	0.00143	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.35e-05	0.00141	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.35e-05	0.00141	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.85e-05	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.85e-05	0.00131	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.85e-05	0.00131	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.81e-05	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.8e-05	0.0013	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.8e-05	0.0013	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.76e-05	0.0013	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.5e-05	0.00125	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.47e-05	0.00124	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.41e-05	0.00123	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.39e-05	0.00123	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.25e-05	0.0012	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.22e-05	0.00119	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.22e-05	0.00119	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.18e-05	0.00119	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.18e-05	0.00119	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.13e-05	0.00118	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.13e-05	0.00118	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.95e-05	0.00114	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.95e-05	0.00114	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.89e-05	0.00113	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.84e-05	0.00112	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.84e-05	0.00112	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.81e-05	0.00111	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.73e-05	0.0011	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.53e-05	0.00106	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.53e-05	0.00106	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.38e-05	0.00103	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.34e-05	0.00102	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.3e-05	0.00102	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.27e-05	0.00101	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.23e-05	0.001	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.06e-05	0.000971	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.99e-05	0.000958	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.55e-05	0.000872	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.55e-05	0.000872	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.48e-05	0.00086	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.42e-05	0.000848	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.34e-05	0.000832	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.34e-05	0.000832	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.14e-05	0.000795	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.14e-05	0.000795	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.12e-05	0.00079	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.07e-05	0.000781	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.06e-05	0.00078	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.91e-05	0.000749	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.85e-05	0.000739	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.73e-05	0.000715	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.67e-05	0.000705	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.67e-05	0.000705	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.49e-05	0.00067	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.49e-05	0.00067	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.46e-05	0.000664	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.43e-05	0.000659	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.37e-05	0.000646	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.32e-05	0.000638	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.32e-05	0.000638	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.14e-05	0.000603	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.13e-05	0.000601	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.98e-05	0.000573	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.98e-05	0.000573	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.9e-05	0.000557	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.74e-05	0.000526	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.74e-05	0.000526	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.7e-05	0.000517	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.69e-05	0.000515	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.69e-05	0.000515	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.62e-05	0.000503	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.49e-05	0.000478	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.44e-05	0.000468	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.26e-05	0.000433	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.26e-05	0.000433	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.08e-05	0.000399	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.06e-05	0.000396	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.06e-05	0.000396	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.02e-05	0.000388	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.94e-05	0.000373	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.88e-05	0.000361	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.84e-05	0.000353	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.82e-05	0.000349	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.7e-05	0.000325	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.000318	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.000293	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.43e-05	0.000275	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.42e-05	0.000272	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.32e-05	0.000253	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.29e-05	0.000248	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.000245	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.000241	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.000225	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000213	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.11e-05	0.000212	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.00021	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.98e-06	0.000191	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.94e-06	0.000191	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.8e-06	0.000188	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.19e-06	0.000176	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.13e-06	0.000175	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.65e-06	0.000166	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.67e-06	0.000147	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.56e-06	0.000145	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.55e-06	0.000145	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	7.22e-06	0.000139	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.05e-06	0.000135	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.68e-06	0.000128	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.88e-06	0.000113	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.63e-06	0.000108	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.54e-06	8.71e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.34e-06	8.33e-05	CbGpPWpGaD
